WO2000023478A1 - Squaric acid activated carrier usable for immobilisation of compounds containing amine groups - Google Patents
Squaric acid activated carrier usable for immobilisation of compounds containing amine groupsInfo
- Publication number
- WO2000023478A1 WO2000023478A1 PCT/SE1999/001861 SE9901861W WO0023478A1 WO 2000023478 A1 WO2000023478 A1 WO 2000023478A1 SE 9901861 W SE9901861 W SE 9901861W WO 0023478 A1 WO0023478 A1 WO 0023478A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- carrier
- activated
- matrix
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Definitions
- the present invention relates to storage stable, activated carrier in the form of matrices including surfaces.
- matrices suitable as carrier to which compounds containing an amine group may be covalently bound.
- the invention also relates to a kit comprising such activated carrier, the kit being shippable to customers by virtue of the long term stability of said carrier.
- carrier/carriers In the context of this description of the invention the words carrier/carriers, matrix/matrices and medium/media are used interchangeable, if not otherwise said.
- the immobilization of biomolecules on various carriers finds great utility in research and industry, and many methods have been disclosed in the literature. These methods comprise an activation of a carrier, e.g. a matrix in the form of a gel, a surface of a polymer bead etc.
- the activation process generally comprises subjecting the carrier to a reactive agent that reacts with -OH groups or amine groups on the carrier, thereby, either directly or subsequent to further steps, forming intermediate reactive structures/sites. These structures may then be reacted with the compound in question, thereby immobilizing the compound.
- Illustrative examples of such methods are the CNBr method, and epoxy activation.
- the activated intermediates obtained by these methods must be freeze dried in order to be shippable to customers. Freeze drying is fairly complicated and in addition require processing at the customer before the freeze dried intermediates can be used.
- an activated carrier comprising reactive squaryl groups said activated carrier being dispensed in aqueous media and having a shelf life of from 1 -2 months up to several months without showing any significant loss in activity.
- the aqueous media is typically an aqueous liquid.
- the object of the present invention is therefore to provide a storage stable activated carrier comprising reactive squaryl groups, said carrier being dispensed in an aqueous medium for use in the immobilization of nucleophilic compounds, typically amine containing compounds.
- the activated medium should be stable during storage and/or resistent against bacterial growth over extended periods of time.
- activated medium or “activated carrier” or “activated matrix” mean a carrier to be used as a carrier for a nucleophilic compound.
- Said carrier has been provided with reactive squaryl groups enabling easy coupling of said compound to said carrier.
- the activated carrier should be regarded as an intermediate in the process of making immobilized forms of said compounds.
- Nucleophilic compounds that are contemplated in the context of the invention typically contain a primary and/or a secondary amine group, for instance proteins or other compounds exhibiting peptide structure or other biomolecules and other organic compounds exhibiting this type of amine groups.
- a carrier as defined above comprising amine groups activated with an electrophilic squaric acid derivative may be stable in aqueous media.
- the rate of hydrolysis of reactive squarate groups bound to carriers is sufficiently slow for enabling storage of the activated carriers in aqueous media.
- a storage stable composition comprising a carrier as defined above and usable for the immobilization of nucleophilic compounds.
- the carrier comprises primary or secondary amino groups that have been activated to carry reactive squaric acid derived groups linked to said primary or secondary amine sites on said carrier, said carrier being in contact with an aqueous medium, e.g. an aqueous liquid.
- kits for storing the composition over extended periods of time this being defined in claim 10.
- composition according to the present invention is stable for an extended period of time as defined above, for instance for a week, a month or even longer periods of time, such as two, three or more months.
- the squaric acid derivatives useful for making the activated carriers may be selected among bifunctional electrophilic squaric acid derivatives, such as dialkoxyesters (e.g. dimethylester, diethylester, dibutylester and also corresponding mixed diester (squarates)), dihalides and diimidazolides. Other reactive derivatives may also be used.
- the activation reaction is normally run in inert media. See Gl ⁇ senkamp WO9515983.
- the reactive group formed on the carrier is too reactive to be stored in the contemplated aqueous media, it may be easily transformed to a group of lower reactivity.
- the formed monohalide group may be transformed to the corresponding ester function, for instance by running the reaction in the presence of an alcohol.
- a reactive intermediate according to the invention may be represented by the general formula
- P represents a matrix (carrier) containing primary and/or secondary amine groups binding to the squaric acid derived structure (squaryl group, e.g. squarate structure) which in turn constitutes the reactive group in the formula above.
- squaric acid derived structure e.g. squarate structure
- a and B independently of each other can be O or S;
- X can be O or S; and • R may represent an inert organic group that together with X and the squaryl group forms an electrophilic structure.
- R is, for instance, a C, to C 30 hydrocarbon group comprising one or more straight, branched or cyclic hydrocarbon chains that may be broken at one or more locations by a thioether sulphur or an ether oxygen and/or substituted with one or more RO- groups where R' is hydrogen and/or C, to C 6 alkyl or corresponding sulphur analogues (R'S-).
- R' is hydrogen and/or C, to C 6 alkyl or corresponding sulphur analogues
- the preferred Rs are C, to C 6 alkyl, such as methyl, ethyl, n-propyl, isopropyl, and possibly also isoforms of butyl.
- R may also be an imidazolide group or another group resulting in the squarate structure in the general formula being a reactive electrophilic squarate group on the carrier.
- R does not contain any group that adversely affect the reactivity of the activated squaryl group shown.
- Destabilizing groups in R may for instance be primary and secondary amines.
- stable is meant that the ability to react with primary and secondary amines is retained for a prolonged time without being significantly or irreproducibly decreased. This in turns means that the activated intermediate can be stable even if the activated intermediate participate in transesterifications with alcohol groups present in the storage media, the carrier or the inert group R.
- matrices exhibiting primary and/or secondary amine groups can be used.
- matrix is to be understood to encompass any physical form such as particles, monoliths, fibers, membranes, tube walls, capillaries, surfaces etc.
- the matrix may be porous or non-porous and soluble, insoluble or insolubilizable in aqueous media or other liquids.
- the matrix is based on a polymer that exposes a hydrophilic surface to the aqueous media used, i.e. expose hydroxy (-OH), carboxy (-
- the matrix is of the same kind as those normally used as chromatographic matrices.
- the polymer may, for instance, be based on polysaccharides, such as dextran, starch, cellulose, pullulan, agarose etc, which if necessary have been cross- linked, for instance with bisepoxides, epihalohydrins, 1,2,3-trihalo substituted lower hydrocarbons, to provide a suitable porosity and rigidity.
- the matrix may also be based on synthetic polymers, such as polyvinyl alcohol, poly hydroxyalkyl acrylates, poly hydroxyalkyl methacrylates, poly acrylamides, polymethacrylamides etc.
- synthetic polymers such as polyvinyl alcohol, poly hydroxyalkyl acrylates, poly hydroxyalkyl methacrylates, poly acrylamides, polymethacrylamides etc.
- hydrophobic polymers such as those based on divinyl and monovinyl substituted benzenes
- the surfaces of the matrix are often hydrophilized to expose hydrophilic groups as defined above to a surrounding aqueous liquid.
- the matrices may also be of inorganic nature, e.g. silica, zirconium oxide etc.
- the matrices as such do not exhibit amine functionality they may be derivatized by methods known by the man skilled in the art to do so.
- the storage medium for the intermediates in question is aqueous, typically in form of an aqueous liquid. It preferably comprises an antibacterially active component. This component preferably is selected form organic solvents suitably miscible with water.
- a preferred class of components is alcohols, in particular alkanols, such as methanol, ethanol, propanol, iso-propanol, butanol, sec-butanol, tert-butanol.
- alkanols such as methanol, ethanol, propanol, iso-propanol, butanol, sec-butanol, tert-butanol.
- the most preferred alcohol is ethanol.
- the amount of the antibacterial component needed is an amount sufficient for preventing bacterial or microbial growth in the composition.
- the composition of the aqueous medium may comprise water in an amount of 5-100 %, preferably 20-95 %, more preferably 40-85 %.
- the amount of organic solvent suitably miscible with water is in the interval 5-95 %, preferably 5-80 %, more preferably 10-60 % such as 25-60 . Volume-% (v/v) is contemplated.
- the organic solvent is preferably a water- miscible alcohol.
- the pH of the aqueous medium may be in the range 5-9. Standard buffer systems that do not adversely affect the stability may be used, e.g. 0.3 M borate buffer. Amine buffers, in particular adjusted to pH below 1 minus their pKa should be avoided.
- the activated carrier When being used the activated carrier is contacted with an organic compound containing an amine group under conditions permitting binding of the amine compound to the carrier via a newly formed squarate amide structure.
- the compound containing the amine function is preferably a bioorganic molecule.
- the amine compound is a member of a so- called affinity pair.
- affinity pairs are antigen/hapten - antibody, carbohydrate structure - lectin, complementary nucleic acid sequences and any other native or synthetic ligand-receptor pair in which the ligand and receptor are able to cling to each other via affinity.
- affinity pairs One special class of affinity pairs has biological origin. They are consequently called bioaffinity pairs.
- RNH 2 is the compound to be immobilized to the matrix.
- the scheme is focusing on one kind of introduced amino groups. The reaction will in principle be the same for the other amino groups.
- Figure 1 gives a graph showing the long-term stability of a composition according to the invention.
- the amino acid analysis data shown correspond to coupling yields of 75-85 %. We have immobilized other ligands with similar or higher yields.
- Polymer beads (Sephacryl S-200, Amersham Pharmacia Biotech AB, Uppsala, Sweden) were amine functionalized in the following way.
- Epoxy activated beads were washed with water and drained, and then added to a reaction vessel and an equal volume of 1 M NH 3 was added to the vessel. The vessel was sealed and circle shaken in a water bath at 50°C for 23 h. The beads were washed with water (>10 x gel volume) and stored in 20% ethanol in water at +2 - +8°C.
- the beads will contain different amino groups -CH 2 CHOHCH 2 NH 2 (obtained by reaction of ammonia with epoxy groups), -NHCOCH 2 CHNH 2 (obtained by reaction of ammonia with acrylamido groups and corresponding crosslinking groups obtained via further reaction with epoxy and acrylamido groups.
- Example 2 (Activation of aminated matrix with 3,4-diethoxy-squarate)
- the amine functionalised Sephacryl (100 ml, from Example 1) stored in 20% EtOH, was washed with absolute ethanol (10 x 1 gel volumes). The beads were added to a flask with screw cap. An equal volume of absolute ethanol was added followed with benzyl alcohol (ca 250 ⁇ l/50 ml ethanol) and the squarate (ca 1.5-2 equivalents compared to the amine contents of the beads). The reagents were mixed and a small sample of the liquid phase, used as reference for HPLC, was taken out immediately. The flask was shaken in a water- bath at 20-60 °C.
- the beads were washed with ethanol 99.5 % followed with 20 % ethanol.
- the activated beads were divided in 10 ml samples slurried in 20% ethanol and stored at 2-8°C.
- the activated beads stored in 20% EtOH, were washed with water (ca 5 x 1 gel volume, gv), followed with a borate buffer 0.3M borate 1.5 M Na2SO4, pH 9.
- the enzyme solution was made by dissolving 100 mg Porcine trypsin in ca 10 ml 0.5 M Na2SO4 and 0.3 M borate buffer pH 9 which was added to the beads The mixture was shaken at room temperature for 6 hrs.
- the beads were washed with tris buffer (0.1 M, 0.5 M NaCl, pH 8) 4x1 gel volumes.
- tris buffer 0.1 M, 0.5 M NaCl, pH 8
- the storage medium used in the examples is 20% ethanol in water, temperature 2-8°C
- Stability tests on the intermediates in the storage mode according to the present invention were made by taking samples of the intermediates at irregular intervals during 66 weeks (more precisely at 1, 6, 10, 12, 18, 26, 40 and 66 weeks).
- Figure 1 shows the results from the storage test. From this figure it can be concluded that within the experimental errors, the intermediates are stable in the aqueous storage medium over an extended period of time, i.e. at least about 66 weeks.
- composition according to the invention is suitably prepared by replacing the liquid reaction medium from the activated carrier medium, for instance by washing, with the aqueous medium that ultimately will be used for storing the composition.
- the composition is delivered to the customer as a kit comprising a storage container containing the composition, i.e. the activated medium in contact with the aqueous medium.
- a storage container containing the composition
- Such storage means can comprise bottles, ampoules, flasks, and other closed vessels not permitting evaporation.
- carrier media in the form of open surfaces (e.g. wells of a microtiter plate), and monolithic porous and nonporous matrices, strips and the like, the medium itself may function as the storage means, provided there is an appropriate cover means preventing evaporation from the activated surface.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU14263/00A AU772324B2 (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier usable for immobilisation of compounds containingamine groups |
| EP99970668A EP1137669B1 (en) | 1998-10-16 | 1999-10-14 | Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| CA002346871A CA2346871A1 (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| US09/807,463 US6656876B1 (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier usable for immobilization of compounds containing amine groups |
| JP2000577203A JP2002527526A (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier useful for immobilization of compounds containing amine groups |
| DE69933310T DE69933310T2 (en) | 1998-10-16 | 1999-10-14 | STABILIZED COMPOSITION CONTAINING SQUARE ACTION ACTIVATED CARRIER WHICH CAN BE USED FOR THE IMMOBILIZATION OF AMINGRUPPEN CONTAINING SUBSTANCES |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803565A SE9803565D0 (en) | 1998-10-16 | 1998-10-16 | Media and kit containing said media |
| SE9803588-4 | 1998-10-19 | ||
| SE9803565-2 | 1998-10-19 | ||
| SE9803588A SE9803588D0 (en) | 1998-10-19 | 1998-10-19 | Medium and kit containing said medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2000023478A1 true WO2000023478A1 (en) | 2000-04-27 |
Family
ID=26663419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SE1999/001861 Ceased WO2000023478A1 (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6656876B1 (en) |
| EP (1) | EP1137669B1 (en) |
| JP (1) | JP2002527526A (en) |
| AT (1) | ATE340192T1 (en) |
| AU (1) | AU772324B2 (en) |
| CA (1) | CA2346871A1 (en) |
| DE (1) | DE69933310T2 (en) |
| ES (1) | ES2272099T3 (en) |
| WO (1) | WO2000023478A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001069255A3 (en) * | 2000-03-15 | 2002-02-07 | Gluesenkamp Karl Heinz | Production, stabilisation and use of a novel type of chemically activated surfaces |
| WO2003035672A1 (en) * | 2001-10-25 | 2003-05-01 | Lundonia Biotech Ab | Novel method for recovery of squaric acid mono esters in bioconjugation chemistry |
| WO2003084982A3 (en) * | 2001-11-14 | 2004-09-10 | Luminex Corp | Functionalized compositions for improved immobilization |
| WO2005116081A3 (en) * | 2004-05-24 | 2006-07-06 | Genvault Corp | Stable protein storage and stable nucleic acid storage in recoverable form |
| WO2010031007A3 (en) * | 2008-09-12 | 2010-07-29 | Genvault Corporation | Matrices and media for storage and stabilization of biomolecules |
| CN107531799A (en) * | 2015-04-13 | 2018-01-02 | 富士胶片株式会社 | The manufacture method and short-chain peptide fixation support of short-chain peptide fixation support |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2563040C (en) * | 2004-04-30 | 2012-07-17 | Sumitomo Chemical Company, Limited | Polymer having oxocarbon group, and use thereof |
| JP4752318B2 (en) * | 2004-04-30 | 2011-08-17 | 住友化学株式会社 | Polymer having oxocarbon group and use thereof |
| JP4988578B2 (en) * | 2004-10-12 | 2012-08-01 | ルミネックス コーポレーション | Method for changing the surface properties of microspheres |
| US8138231B2 (en) * | 2007-10-29 | 2012-03-20 | Sumitomo Chemical Company, Limited | Polymer having oxycarbon group, and use thereof |
| US9980930B2 (en) | 2014-10-16 | 2018-05-29 | The University Of Melbourne | Imaging composition and uses thereof |
| CN111495328B (en) * | 2020-04-24 | 2022-05-17 | 太原理工大学 | Ammonia modification method of calcium squarate and application of ammonia modification method in efficient separation of ethylene and ethane |
| CN118703608A (en) * | 2020-11-16 | 2024-09-27 | 深圳市真迈生物科技有限公司 | Compound modified chip and its preparation method and application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995015983A1 (en) * | 1993-12-06 | 1995-06-15 | Gluesenkamp Karl Heinz | Process for immobilising biomolecules and affinity ligands on polymer carriers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS148930B1 (en) * | 1970-09-16 | 1973-05-24 | ||
| US5028535A (en) * | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| SE500248C2 (en) * | 1992-12-03 | 1994-05-24 | Eka Nobel Ab | Chiral adsorbents and their preparation as well as compounds on which the adsorbents are based and their preparation |
| US5691152A (en) * | 1995-11-09 | 1997-11-25 | E. R. Squibb & Sons, Inc. | Stable avidin composition |
| SE9700768D0 (en) * | 1997-03-04 | 1997-03-04 | Pharmacia Biotech Ab | Procedure for introducing functionality |
-
1999
- 1999-10-14 ES ES99970668T patent/ES2272099T3/en not_active Expired - Lifetime
- 1999-10-14 AU AU14263/00A patent/AU772324B2/en not_active Ceased
- 1999-10-14 CA CA002346871A patent/CA2346871A1/en not_active Abandoned
- 1999-10-14 EP EP99970668A patent/EP1137669B1/en not_active Expired - Lifetime
- 1999-10-14 AT AT99970668T patent/ATE340192T1/en not_active IP Right Cessation
- 1999-10-14 DE DE69933310T patent/DE69933310T2/en not_active Expired - Fee Related
- 1999-10-14 US US09/807,463 patent/US6656876B1/en not_active Expired - Fee Related
- 1999-10-14 WO PCT/SE1999/001861 patent/WO2000023478A1/en not_active Ceased
- 1999-10-14 JP JP2000577203A patent/JP2002527526A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995015983A1 (en) * | 1993-12-06 | 1995-06-15 | Gluesenkamp Karl Heinz | Process for immobilising biomolecules and affinity ligands on polymer carriers |
Non-Patent Citations (2)
| Title |
|---|
| K.-H. GLUESENKAMP ET AL.: "Squaric Acid Diethylester: A Simple and Convenient Coupling Reagent", Z. NATURFORSCH., vol. 46C, 1991, pages 498 - 501, XP002926994 * |
| LUTZ F. TIETZE ET AL.: "Conjugation of p-Aminophenyl Glycosides with Squaric Acid Diester to a Carrier Protein and the Use of Neoglycoprotein in the Histochemical Detection of Lectins 1", BIOCONJUGATE CHEM., vol. 2, 1991, pages 148 - 153, XP002926995 * |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001069255A3 (en) * | 2000-03-15 | 2002-02-07 | Gluesenkamp Karl Heinz | Production, stabilisation and use of a novel type of chemically activated surfaces |
| WO2003035672A1 (en) * | 2001-10-25 | 2003-05-01 | Lundonia Biotech Ab | Novel method for recovery of squaric acid mono esters in bioconjugation chemistry |
| US8188269B1 (en) | 2001-11-14 | 2012-05-29 | Luminex Corporation | Functionalized compositions for improved immobilization |
| WO2003084982A3 (en) * | 2001-11-14 | 2004-09-10 | Luminex Corp | Functionalized compositions for improved immobilization |
| JP2005532533A (en) * | 2001-11-14 | 2005-10-27 | ルミネックス・コーポレーション | Functionalized compositions for improved immobilization |
| US7241883B2 (en) | 2001-11-14 | 2007-07-10 | Luminex Corporation | Functionalized compositions for improved immobilization |
| US7385053B2 (en) | 2001-11-14 | 2008-06-10 | Luminex Corporation | Functionalized compositions for improved immobilization |
| WO2005116081A3 (en) * | 2004-05-24 | 2006-07-06 | Genvault Corp | Stable protein storage and stable nucleic acid storage in recoverable form |
| US7589184B2 (en) | 2004-05-24 | 2009-09-15 | Genvault Corporation | Stable protein storage and stable nucleic acid storage in recoverable form |
| WO2010031007A3 (en) * | 2008-09-12 | 2010-07-29 | Genvault Corporation | Matrices and media for storage and stabilization of biomolecules |
| US8283165B2 (en) | 2008-09-12 | 2012-10-09 | Genvault Corporation | Matrices and media for storage and stabilization of biomolecules |
| CN102177237B (en) * | 2008-09-12 | 2013-10-30 | 金沃特公司 | Matrices and media for storage and stabilization of biomolecules |
| US8951719B2 (en) | 2008-09-12 | 2015-02-10 | Gentegra, LLC. | Matrices and media for storage and stabilization of biomolecules |
| US9637513B2 (en) | 2008-09-12 | 2017-05-02 | Gentegra Llc | Matrices and media for storage and stabilization of biomolecules |
| US10160997B2 (en) | 2008-09-12 | 2018-12-25 | Gentegra Llc | Matrices and media for storage and stabilization of biomolecules |
| CN107531799A (en) * | 2015-04-13 | 2018-01-02 | 富士胶片株式会社 | The manufacture method and short-chain peptide fixation support of short-chain peptide fixation support |
| EP3284757A4 (en) * | 2015-04-13 | 2018-02-21 | FUJIFILM Corporation | Method of producing short-chain peptide immobilization carrier and short-chain peptide immobilization carrier |
| US10927188B2 (en) | 2015-04-13 | 2021-02-23 | Fujifilm Corporation | Method for producing short-chain peptide-immobilized carrier, and short-chain peptide-immobilized carrier |
| CN107531799B (en) * | 2015-04-13 | 2021-11-26 | 富士胶片株式会社 | Method for producing short-chain peptide-immobilized carrier, and short-chain peptide-immobilized carrier |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1137669B1 (en) | 2006-09-20 |
| ES2272099T3 (en) | 2007-04-16 |
| DE69933310T2 (en) | 2007-05-10 |
| AU772324B2 (en) | 2004-04-22 |
| EP1137669A1 (en) | 2001-10-04 |
| CA2346871A1 (en) | 2000-04-27 |
| ATE340192T1 (en) | 2006-10-15 |
| US6656876B1 (en) | 2003-12-02 |
| JP2002527526A (en) | 2002-08-27 |
| DE69933310D1 (en) | 2006-11-02 |
| AU1426300A (en) | 2000-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1137669B1 (en) | Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups | |
| US5405766A (en) | Immobilization of biologically active protein on a support with a 7-18 carbon spacer and a bifunctional phospholipid | |
| US4822681A (en) | Activated polymer solid bodies and processes for the production thereof | |
| US3836433A (en) | Fixation of nitrogenous materials | |
| US4722906A (en) | Binding reagents and methods | |
| US4175073A (en) | Reactive derivatives of HS-group-containing polymers | |
| US5085779A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| EP0154315B1 (en) | Improved diazonium affinity matrixes | |
| US4582875A (en) | Method of activating hydroxyl groups of a polymeric carrier using 2-fluoro-1-methylpyridinium toluene-4-sulfonate | |
| JPH08503066A (en) | Method of chemical bonding to solid phase | |
| IL95772A (en) | Ligand containing medium for chromatographic separation, its preparation and its use for isolating synthetic or natural molecules from a fluid mixture | |
| JPS6027517B2 (en) | Method for immobilizing proteins by polymerizing on the spot | |
| Miron et al. | Polyacrylhydrazido-agarose: Preparation via periodate oxidation and use for enzyme immobilization and affinity chromatography | |
| US5563215A (en) | Method of attaching dialdehyde starch to a surface and products produced by that method | |
| CA1332598C (en) | Polyethyleneimine matrixes for affinity chromatography | |
| US4828996A (en) | Materials and method for immobilizing biologically active substances | |
| US5395856A (en) | HPLC avidin monomer affinity resin | |
| AU583060B2 (en) | Sulphuryl chloride/polyamide derivatives | |
| CS208781B2 (en) | Method of determination of the bonding index in the blood serum | |
| CA1316858C (en) | Method and device for attachment of biologically useful materials to a solid phase | |
| JPH0634633A (en) | Hen's egg antibody fixation carrier and its production | |
| JPH07308575A (en) | Functional material fixing agent | |
| JPH02226070A (en) | Method for determining glycoprotein | |
| JPH05261281A (en) | Carrier for immobilizing bioactive substance and its production | |
| US7575908B1 (en) | Immobilization method for producing active α1-acid glycoprotein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 14263 Kind code of ref document: A Format of ref document f/p: F |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2346871 Country of ref document: CA Ref country code: CA Ref document number: 2346871 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 14263/00 Country of ref document: AU |
|
| ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 577203 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1999970668 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09807463 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1999970668 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 14263/00 Country of ref document: AU |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1999970668 Country of ref document: EP |


